Several novel therapies are now accessible in the United Kingdom for treating type 2 diabetes . Wegovy , Rybelsus , and Mounjaro represent different approaches, with Saxenda and Mounjaro being injectable peptide receptor activators primarily aimed at weight management alongside glucose control ,